Flexion Therapeutics’ new non-opioid drug has been approved to treat knee pain, but the company will also likely explore any potential it could have for other areas of the body, its CEO told CNBC on Monday.

On Friday, shares of Flexion soared more than 10 percent after the Food and Drug Administration approved<a href=”https:/…
Health Care


Leave a Reply

Your email address will not be published. Required fields are marked *